Last Updated on September 17, 2026
Gastroenterology CPT coding depends on what actually happens during the procedure. A diagnostic EGD may progress to biopsy or lesion removal. A screening colonoscopy may become therapeutic after a polyp is identified. Multiple lesions treated with different techniques can also change how CPT codes and modifiers apply.
Accurate GI billing therefore depends on more than selecting a familiar procedure code. Procedure intent, anatomical route, technique, findings, diagnosis, modifiers, and operative documentation all need to support the final claim.
That makes GI coding especially dependent on clear procedure documentation and accurate translation of what occurred during the encounter into the appropriate CPT code.
Table of contents
- Most Common Gastroenterology CPT Codes
- EGD CPT Codes
- Colonoscopy CPT Codes
- Through-Stoma Colonoscopy CPT Codes
- Capsule Endoscopy CPT Codes
- GI Billing Rules to Watch in 2026
- When Screening Colonoscopy Becomes Diagnostic or Therapeutic
- When Multiple GI Procedures Can Be Reported Together
- GI Modifiers
- What GI Coders Need From the Operative Note
- Why Correct GI CPT Codes Still Get Denied
- How to Choose the Right GI CPT Code
- Turning GI Procedure Detail Into Accurate Claims
- FAQs
Most Common Gastroenterology CPT Codes
GI CPT code selection is primarily driven by procedure route and technique.
The most important question for the coder is not simply which scope was performed, but what happened once the scope was performed.
EGD CPT Codes
Upper GI coding can change during the same encounter as findings lead to additional intervention.
CPT 43235 Diagnostic EGD
Use 43235 for a qualifying diagnostic upper GI endoscopy when no separately reportable biopsy or therapeutic intervention is performed.
Coding checkpoint: Before finalizing 43235, confirm whether biopsy, lesion removal, dilation, stent placement, or another separately reportable service occurred.
For a deeper look at this specific code, including documentation and modifier considerations, see our CPT 43235 EGD Coding and Billing Guide.
CPT 43239 EGD With Biopsy
Use 43239 when qualifying biopsy sampling occurs during EGD.
Rather than documenting only “biopsy taken,” the operative report should allow the coder to identify:
- biopsy site
- clinical reason for sampling
- relevant findings
- specimen information where applicable
Example: An EGD performed for suspected celiac disease includes duodenal biopsies. The biopsy changes the coding pathway from diagnostic EGD alone to the applicable biopsy service.
CPT 43251 EGD With Snare Removal
Use 43251 when a qualifying lesion is removed using a snare technique.
What changes the code? The technique.
“Lesion removed” does not tell the coder whether removal occurred by biopsy, snare, EMR, or another method.
CPT 43254 EGD With Endoscopic Mucosal Resection
Use 43254 when the documentation supports qualifying endoscopic mucosal resection.
The operative note should make the EMR technique identifiable and describe the lesion sufficiently to distinguish it from a simpler biopsy or snare procedure.
CPT 43266 EGD With Stent Placement
Use 43266 for qualifying endoscopic stent placement.
The billing team should also determine which procedural components are already included in the primary service. CMS NCCI guidance requires services included within a more comprehensive procedure to remain bundled unless separate reporting is appropriately supported.
Colonoscopy CPT Codes
Colonoscopy coding is heavily influenced by what the physician finds and the technique used during the procedure.
| CPT Code | Procedure/Finding | Key Billing Consideration |
|---|---|---|
| 45378 |
Diagnostic colonoscopy with no separately reportable intervention
|
Confirm that no biopsy, snare removal, EMR, or other separately reportable therapeutic service was performed. |
| 45380 |
Colonoscopy with biopsy
|
Document the biopsy site and connect the intervention to the relevant finding. |
| 45385 |
Colonoscopy with snare removal
|
Clearly identify the snare technique rather than simply stating “polyp removed.” |
| 45390 |
Colonoscopy with endoscopic mucosal resection
|
Documentation should support EMR and distinguish it from biopsy or standard snare removal. |
| 45398 |
Colonoscopy with band ligation
|
Identify the condition treated and confirm band ligation as the technique performed. |
Example: If the operative note says only “two polyps removed,” the coder still cannot determine whether the physician used biopsy forceps, a snare, EMR, or another removal technique. The operative note should identify the technique used for each lesion.
Through-Stoma Colonoscopy CPT Codes
When colonoscopy is performed through a stoma, the route changes the applicable code family.
- 44388: diagnostic colonoscopy through stoma
- 44389: through-stoma colonoscopy with biopsy
- 44394: through-stoma colonoscopy with snare removal
- 44402: qualifying through-stoma colonoscopy with stent placement
Documentation checkpoint: The operative note should establish the stoma as the point of entry and describe any intervention performed.
Using a standard colonoscopy code when the procedure was actually performed through a stoma can misrepresent the service.
Capsule Endoscopy CPT Codes
Capsule studies introduce a different billing consideration because code selection must also align closely with coverage and authorization.
CPT 91110
- Used for qualifying capsule imaging of the gastrointestinal tract, commonly involving small-bowel evaluation.
- The claim should be supported by the clinical indication, physician interpretation, and applicable coverage criteria.
CPT 91113
- Applies to qualifying colon capsule imaging.
- Coverage may vary based on the indication and payer.
When a payer requires approval before the procedure, a correct CPT code cannot compensate for missing authorization.
For practices managing payer approval for capsule studies and other advanced GI procedures, our Prior Authorization Services can help connect documentation, payer submission, follow-up, and authorization before billing begins.
GI Billing Rules to Watch in 2026
Several Medicare rules can affect how otherwise familiar GI CPT codes are billed in 2026.
Screening Colonoscopy Coinsurance Remains 15%
Medicare cost-sharing rules continue to distinguish qualifying screening procedures that become diagnostic or therapeutic.
2026 Medicare Billing Point: Screening classification can directly affect both claim processing and beneficiary cost sharing.
Follow-On Colonoscopy Rules
Medicare includes qualifying follow-on colonoscopy after certain positive covered colorectal cancer screening tests within its complete screening policy.
Applicable KX modifier requirements should therefore be reviewed before treating these encounters as routine diagnostic colonoscopies.
NCCI Rules Remain Important
Current NCCI rules remain important when multiple endoscopic techniques are performed during the same encounter.
When Screening Colonoscopy Becomes Diagnostic or Therapeutic
One of the most important GI billing distinctions is between why the procedure began and what ultimately happened during it.
GI coding risk often appears when the procedure changes from what was scheduled to what was actually performed. Keeping screening intent, findings, technique and final procedure status visible from scheduling through coding reduces the need to reconstruct the encounter later.
Commercial plans may have different preventive-service requirements, so Medicare logic should not automatically be applied to every payer.
Applies to qualifying screening colorectal procedures that become diagnostic or therapeutic during the same clinical encounter when Medicare requirements are met.
When Multiple GI Procedures Can Be Reported Together
Same Lesion
If biopsy and snare removal involve the same lesion, a modifier should not be appended simply to bypass an NCCI edit.
The presence of two techniques alone does not establish two separately reportable services.
Separate Lesions
If biopsy and snare removal are performed on separate lesions, the NCCI edit between 45385 and 45380 may be appropriately bypassed with modifier 59 or XS when documentation supports separate reporting.
Example:
- Ascending colon polyp removed by snare
- Separate sigmoid lesion biopsied
The operative report should identify both lesion locations and the technique used at each site.
A different diagnosis alone does not establish separate reporting. The record should support the distinct lesion, anatomical site, procedure, or other qualifying circumstance.
When the same NCCI or modifier issue keeps recurring, a Medical Coding Audit can help determine whether the root cause lies in documentation, code assignment, or modifier logic.
Review High-Risk GI Claims Before Submission
AnnexMed helps validate multi-procedure coding, lesion documentation, and modifiers before payer edits create rework.
Review Your GI Billing WorkflowGI Modifiers
Modifiers should explain the circumstances of the GI encounter rather than being applied from a generic internal list.
| Modifier | Where It Fits |
|---|---|
| PT |
Medicare modifier used when an eligible colorectal cancer screening service becomes diagnostic or therapeutic.
|
| 33 |
Qualifying preventive services where applicable under payer policy.
|
| 59 / XS |
Distinct procedures when NCCI requirements for separate reporting are met.
|
| 52 / 53 |
Reduced or discontinued services based on procedure circumstances and payer instructions.
|
Incomplete or discontinued procedures require additional care because physician, facility, Medicare, and commercial payer reporting requirements may differ.
What GI Coders Need From the Operative Note
The operative report should clearly establish:
- Procedure intent: screening, surveillance, or diagnostic
- Anatomy and lesion location
- Technique used: biopsy, snare, EMR, banding, stent, etc.
- Relevant findings
- Specimen site
- Procedure completion
- Separate lesions and techniques, when multiple services are reported
When multiple lesions are treated, the note should also connect the specific lesion with the specific technique.
Why Correct GI CPT Codes Still Get Denied
A correct GI CPT code can still be denied when the surrounding billing details do not support the claim.
- Screening Status Is Wrong
A screening colonoscopy may become therapeutic, but the claim is not updated with the correct payer-specific modifier or classification.
- Documentation Does Not Support the Technique
The note may say “polyp removed” without identifying whether biopsy, snare, or EMR was performed.
- Multiple Procedures Lack Separate-Lesion Support
Codes such as 45380 and 45385 may be reported together without documentation showing that the procedures were performed on separate lesions.
- Diagnosis Does Not Match the Procedure
The CPT code may be correct, but the ICD-10 diagnosis does not reflect the documented clinical reason for the service.
- Prior Authorization Is Missing
Some advanced GI procedures may require payer approval before the service is performed.
- Incomplete Procedures Are Reported Incorrectly
Reduced or discontinued procedures may require different reporting or modifier treatment based on the payer and site of service.
For a deeper look at recurring GI billing issues, see our article on Common Gastroenterology Billing Errors.
For claims that have already been denied, our Denial Management Services can help identify the upstream coding, documentation, authorization, or payer-rule issue.
How to Choose the Right GI CPT Code
Before finalizing a GI claim, work backward from the operative report and confirm how the procedure actually progressed.
Step 1: Confirm the Procedure Intent
Start by identifying whether the encounter was screening, surveillance, or diagnostic. This affects diagnosis selection, preventive-service rules, and modifier requirements.
Step 2: Identify the Procedure Route
Determine whether the physician performed an EGD, standard colonoscopy, through-stoma procedure, or capsule endoscopy. Each route has a different CPT code family.
Step 3: Match the Code to the Technique
Select the code based on what was actually performed, such as diagnostic examination, biopsy, snare removal, EMR, banding, or stent placement.
Step 4: Review Multiple Procedures
When more than one technique is documented, confirm whether they were performed on the same lesion or separate lesions. This determines whether separate reporting and modifiers such as 59 or XS may be appropriate.
Step 5: Account for Changes During the Procedure
A screening procedure may become therapeutic, or an examination may be reduced or discontinued. The final coding should reflect what happened during the encounter rather than only what was originally scheduled.
Step 6: Validate the Complete Claim
Before submission, confirm that the CPT code, diagnosis, modifier, procedure intent, and operative documentation all describe the same clinical encounter.
Turning GI Procedure Detail Into Accurate Claims
Gastroenterology claims leave little room for ambiguity. A missed screening status, unclear removal technique, unsupported modifier, or incomplete operative detail can change how the claim is coded and paid.
AnnexMed helps gastroenterology practices address those risks before submission by bringing GI-specific coding expertise, modifier and NCCI review, operative-documentation validation, prior authorization, and denial intelligence into the same billing workflow.
That gives practices a stronger control point between the procedure room and the payer, where coding decisions can be validated, documentation gaps identified, and high-risk claims corrected before they turn into avoidable rework or delayed reimbursement.
Strengthen the Handoff From Procedure to Payment
AnnexMed brings GI-specific coding, operative-documentation review, prior authorization, modifier validation, and denial follow-up together in one billing workflow.
Talk to Our Gastroenterology Billing ExpertFAQs
45378 applies to a qualifying diagnostic colonoscopy without a separately reportable biopsy or therapeutic intervention. When a qualifying biopsy is performed, 45380 may apply based on the documented service.
Under Medicare rules, PT is used when a qualifying colorectal cancer screening procedure becomes diagnostic or therapeutic during the same encounter. For qualifying claims in 2026, applicable coinsurance is reduced to 15% and the deductible remains waived.
They may be separately reportable when biopsy and snare removal are performed on separate lesions and the record supports the distinction. CMS allows modifier 59 or XS in the appropriate separate-lesion circumstance.
No. A qualifying follow-on colonoscopy after a positive covered stool-based screening test may remain part of Medicare’s complete colorectal cancer screening process. KX is used when the applicable Medicare requirements are met.
The record should establish procedure intent, anatomy, findings, technique, specimen details, completion status, and the relationship between lesions and techniques when multiple interventions are performed.
Authorization gaps, unsupported modifier use, NCCI edits, diagnosis mismatches, incomplete documentation, and payer-specific coverage rules can affect payment even when the CPT code itself is correct.



